Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Operating Expenses (2022 - 2025)

Bioregenx (BRGX) has 4 years of Operating Expenses data on record, last reported at $434856.0 in Q3 2025.

  • For Q3 2025, Operating Expenses fell 46.24% year-over-year to $434856.0; the TTM value through Sep 2025 reached $20.1 million, up 215.97%, while the annual FY2024 figure was $24.4 million, 326.93% up from the prior year.
  • Operating Expenses reached $434856.0 in Q3 2025 per BRGX's latest filing, down from $459715.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $18.6 million in Q4 2024 and bottomed at $13474.0 in Q3 2022.
  • Average Operating Expenses over 4 years is $2.1 million, with a median of $598646.0 recorded in 2025.
  • Peak YoY movement for Operating Expenses: surged 22460.15% in 2023, then crashed 82.72% in 2025.
  • A 4-year view of Operating Expenses shows it stood at $14449.0 in 2022, then surged by 3980.43% to $589582.0 in 2023, then surged by 3061.49% to $18.6 million in 2024, then plummeted by 97.67% to $434856.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $434856.0 in Q3 2025, $459715.0 in Q2 2025, and $598646.0 in Q1 2025.